title: FDA treads carefully with PrEP.
authors.forename: David
authors.initials: D
authors.lastname: Holmes
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018890:Chemoprevention; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017277:Drug Approval; D004338:Drug Combinations; D024882:Drug Resistance, Viral; D000068679:Emtricitabine; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D055118:Medication Adherence; D063065:Organophosphonates / Q000627:therapeutic use*; D000068698:Tenofovir; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D019380:Anti-HIV Agents; D004338:Drug Combinations; D063065:Organophosphonates; D003841:Deoxycytidine; D000068698:Tenofovir; D000068679:Emtricitabine; D000225:Adenine